What is the fat-to-muscle loss ratio on retatrutide?

Trial DEXA Data

TRIUMPH-1 substudies used DEXA scans to measure body composition changes. Results at the 12 mg maintenance dose over 48 weeks:

• Total body weight loss: 24.2%
• Fat mass loss: 32.8%
• Lean mass loss: 8.5%
• Approximate ratio: 75% fat loss / 25% lean mass loss

Comparison to Other GLP-1 Class

DEXA data from various trials:

Semaglutide 2.4 mg

• Weight loss: ~15%
• Fat loss: ~61%
• Lean mass loss: ~39%

Tirzepatide 15 mg

• Weight loss: ~22%
• Fat loss: ~66%
• Lean mass loss: ~34%

Retatrutide 12 mg

• Weight loss: ~24%
• Fat loss: ~75%
• Lean mass loss: ~25%

Retatrutide shows the most favorable ratio of the class.

Why Retatrutide Is Better for Body Composition

Glucagon receptor effect

• Glucagon preferentially mobilizes fat (hepatic lipolysis)
• Increases basal metabolic rate through fat oxidation
• Shifts substrate utilization toward fat rather than muscle protein

Preserved metabolic activity

• Less metabolic adaptation (lower drop in BMR) than pure GLP-1
• Maintained energy expenditure preserves lean mass better
• "Burn" effect doesn't require muscle breakdown

Enhanced nutrient utilization

• Better protein utilization when intake is adequate
• Improved amino acid sensing in muscle tissue

Absolute Muscle Loss in Real Numbers

For a 250 lb patient with 80 lbs lean mass losing 60 lbs on retatrutide:

• Fat loss: 45 lbs
• Lean mass loss: 15 lbs
• End weight: 190 lbs with 65 lbs lean mass

Compare to tirzepatide (same 60 lb loss):

• Fat loss: 40 lbs
• Lean mass loss: 20 lbs

Why 25% Lean Mass Loss Is Still Concerning

• Lean mass is metabolically expensive tissue
• Losing 15 lbs of lean mass means 15 lbs less muscle, bone, organ tissue
• Reduces future metabolic rate
• May affect strength and functional capacity
• Contributes to weight regain risk

Even a "best-in-class" ratio is worse than what's achievable with resistance training and proper protein — lean mass loss can be reduced to 10–15% of total weight loss with proper protocol.

Protocol to Minimize Lean Mass Loss

Protein intake target

• 1.4–1.8 g/kg body weight/day minimum
• Higher end for older adults or those concerned about lean mass
• Distributed across 3–4 meals (20–40 g per meal)
• Adequate during dose escalation when appetite is most suppressed

Resistance training

• Minimum 3 sessions/week
• Compound movements (squat, deadlift, rows, presses)
• 6–12 rep range for hypertrophy
• Progressive overload (adding weight or reps over weeks)
• Continue through the weight loss phase, not just after

Supplement priorities

• Creatine monohydrate 5 g/day (best-evidenced muscle preservation supplement)
• Whey protein for convenience and dose density
• Adequate EAAs if appetite is very suppressed

Sleep and recovery

• 7–8 hours per night
• Quality sleep essential for muscle retention
• Manage stress and cortisol

Weight loss rate management

• Target 0.8–1.2% body weight loss per week
• Faster = more lean mass loss
• Consider pausing dose escalation if losing too fast

Body Composition vs Scale Weight

Traditional weight-focused approach

• Scale weight as primary metric
• Doesn't distinguish fat vs lean
• May miss concerning lean mass loss

Body composition focused approach

• DEXA scans every 3–6 months
• InBody or similar BIA monthly
• Track waist circumference alongside weight
• Strength tracking in training

Signs of Excessive Muscle Loss

• Strength declining beyond 10% in compound lifts over 4 weeks
• Visible muscle "flattening" rather than "tightening"
• Significant decrease in waist-to-hip ratio exceeding expected (indicates not just fat loss)
• Fatigue that doesn't improve with weight loss
• Measurable grip strength decline

Interventions If Losing Too Much Muscle

• Increase protein intake
• Add additional resistance training session per week
• Slow weight loss rate
• Ensure adequate total calorie intake
• Consider adding creatine if not already using
• Evaluate for thyroid or hormonal contributions to excess muscle loss
• Maintain cardio at modest level rather than excessive

Visceral Fat Specifics

Retatrutide particularly targets visceral (organ-surrounding) fat through glucagon receptor activation:

• Visceral fat reduction may be 40%+ with 12 mg dose
• Substantially better visceral:total fat ratio than other GLP-1s
• Major improvement in metabolic health markers
• Reduction in hepatic fat (nonalcoholic fatty liver disease)

Bone Density Considerations

• Rapid weight loss can affect bone density
• Retatrutide data on bone density still emerging
• Weight-bearing exercise and adequate calcium/vitamin D important
• Bone density scan reasonable at 12 months
• Post-menopausal women at highest risk, warrant closer monitoring

Long-Term Body Composition

During maintenance

• Body composition stabilizes
• Continued resistance training can slowly recover some lean mass
• Full muscle recovery requires caloric surplus (or at least maintenance)
• Typical post-weight-loss: slow improvement in body composition over months

After cessation

• Regain tends to be disproportionately fat, not muscle
• Makes future weight cycles progressively worse for body composition
• Strong argument for maintenance rather than repeated cessation-regain cycles

Bottom Line

Retatrutide produces the best fat-to-muscle loss ratio in the GLP-1 class — 75% fat, 25% lean mass at 12 mg. This is a significant improvement over semaglutide (60/40). However, lean mass loss is still substantial and preventable with proper protocol: 1.4+ g/kg protein, resistance training 3×/week, creatine, adequate sleep, and managed rate of loss. Body composition-focused tracking (not just scale weight) is essential for optimizing outcomes.

See the retatrutide guide. Related: trial results, dosage protocol.